Orphan Drug Congress 2011

Development of orphan and ultra orphan drugs to prevent, diagnose and treat rare diseases is very challenging due to its niche nature. On the other hand, rare diseases show the potential of less intense competition, faster and less expensive development, and lower marketing spend on a small, highly motivated audience.

Fleming Europe invites you to Orphan Drug Congress 2011. We have gathered worldwide Pharma specialists who will share their knowledge with you. Hear them speak about regulatory landscape for orphan drug development, discuss how to overcome challenges of orphan drug development and commercialization and examine marketing authorization challenges. Come and listen to real life case studies, discover innovative approaches and benefit from interactive discussions with your peers to benchmark your experiences.

At this conference, you will have the chance to meet true market leaders, top speakers and real experts from pharmaceutical industry. Do not miss the opportunity to gain new knowledge and join us at this event of the year.

For speaking and panelist opportunities please contact:

Alexandra Stanakova, Conference Producer

alexandra.stanakova@flemingeurope.com

T:+421 257 272 121

F: +421 255 644 490

For sponsorship opportunities please contact:

Paul Clark

paul.clark@flemingeurope.com

T: +36 1 411 1840

F: +36 1 411 1841